PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGEN
- 1 March 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (3), 806-812
- https://doi.org/10.1016/s0022-5347(05)67809-3
Abstract
Purpose: At low prostate specific antigen (PSA) the indication for prostate biopsy is usually an abnormal digital rectal examination. We evaluate the diagnostic value of PSA, digital rectal examina...Keywords
This publication has 35 references indexed in Scilit:
- Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)International Journal of Cancer, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI Journal of the National Cancer Institute, 1999
- Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)The Prostate, 1999
- Evaluation of prostate‐specific antigen, digital rectal examination and transrectal ultrasonography in population‐based screening for prostate cancer: improving the efficiency of early detectionBritish Journal of Urology, 1997
- The Free-to-Total Serum Prostate Specific Antigen Ratio for Staging Prostate CarcinomaJournal of Urology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Prospective Evaluation Plan for Randomised Trials of Prostate Cancer ScreeningJournal of Medical Screening, 1996
- The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA densityUrology, 1995
- The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 menUrology, 1995
- Ethics of a prostate cancer screening trialThe Lancet, 1994